An endogenous nanomineral chaperones luminal antigen and peptidoglycan to intestinal immune cells. by Powell, Jonathan et al.
An Endogenous Nanomineral Chaperones Luminal Antigen and 
Peptidoglycan to Intestinal Immune Cells
Jonathan J Powell1, Emma Thomas-McKay1, Vinay Thoree1, Jack Robertson1, Rachel E 
Hewitt1, Jeremy N Skepper2, Andy Brown3, Juan Carlos Hernandez-Garrido4, Paul A 
Midgley5, Inmaculada Gomez-Morilla6, Geoffrey W Grime7, Karen J Kirkby7,8, Neil A 
Mabbott9, David S Donaldson9, Ifor R Williams10, Daniel Rios10, Stephen E Girardin11, 
Carolin T Haas1, Sylvaine FA Bruggraber1, Jon D Laman12,13, Yakup Tanriver14, Giovanna 
Lombardi15, Robert Lechler15, Richard P H Thompson1,16, and Laetitia C Pele1
1Medical Research Council Human Nutrition Research, Elsie Widdowson Laboratory, Fulbourn 
Road, Cambridge CB1 9NL, UK 2Cambridge Advanced Imaging Centre, Department of 
Physiology, Development and Neuroscience, Anatomy Building, University of Cambridge, 
Cambridge, CB2 3DY, UK 3Institute for Materials Research, SPEME, University of Leeds, Leeds, 
LS2 9JT, UK 4Departamento de Ciencia de los Materiales e Ingenieria Metalúrgica y Química 
Inorganica, Facultad de Ciencias. Universidad de Cádiz, Campus Universitario Rio San Pedro, 
Puerto Real (Cádiz) 11.510, Spain 5Department of Materials Science and Metallurgy, 27 Charles 
Babbage Road, University of Cambridge, Cambridge, CB3 0FS, UK 6Technische Universitaet 
Dresden, Fakultaet Maschinenwesen, Institut fuer Stroemungsmechanik, 01062 Dresden, 
Germany 7Ion Beam Centre, Advanced Technology Institute, Faculty of Engineering and Physical 
Sciences, University of Surrey, Guilford GU2 7XH, UK 8Institute of Cancer Sciences, The 
University of Manchester, 27 Palatine Road, Withington, Manchester, M20 3LJ, UK 9The Roslin 
Institute and Royal (Dick) School of Veterinary Sciences, University of Edinburgh, Easter Bush, 
Midlothian EH25 9RG, UK 10Department of Pathology, Emory University School of Medicine, 615 
Michael Street, Atlanta, GA 30322, USA 11Department of Laboratory Medicine and Pathobiology, 
1 King’s College Circle, M5S 1A8 Toronto, Canada 12Department of Immunology, Erasmus MC, 
University Medical Centre and MS Centre ErasMS, Rotterdam, PO Box 2040, 3000 CA 
Rotterdam, The Netherlands and Department of Neuroscience/Medical Physiology, UMC 
Reprints and permissions information is available online at www.nature.com/reprints.Users may view, print, copy, and download text 
and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of 
use:http://www.nature.com/authors/editorial_policies/license.html#terms
Correspondence and requests for materials should be addressed to J.J.P.
Author contributions: J.J.P. developed the overall hypothesis and led the work and, with L.C.P., was involved in specific study 
design, data interpretation and writing of the paper. I.G-M., G.W.G. and K.J.K. developed the necessary techniques for, and undertook 
with V.T. and J.J.P., PIXE/nuclear microscopy studies. J.R. and V.T. developed and optimised immuno-staining and carried out cell 
phenotyping for confocal studies which were carried out with J.N.S. who also prepared the samples for HAADF STEM imaging. E.T-
M., J.C.H-G. and P.A.M. were responsible for the HAADF STEM Tomography. E.T-M. assisted A.B. in undertaking the TEM/STEM 
analyses whilst V.T. and E.T-M. worked with J.N.S. to undertake the SEM analyses. R.L. and R.P.H.T. provided mentorship on the 
early development of the work/hypothesis. G.L. and Y.T. undertook the initial feeding study with labelled OVA. S.E.G. developed 
and characterised NOD1/2−/− mice and supported sample analysis of their Peyer’s patches. N.A.M., D.S.D., I.R.W. and D.R. 
designed and undertook the studies to determine the impact of M-cell deficiency on AMCP uptake. J.D.L. provided the antibody and 
expertise for 2E9 staining and interpretation and, alongside A.B., S.F.A.B., R.E.H. and C.T.H., provided rigorous data review and 
discussion with J.J.P. and L.C.P. All authors contributed to data interpretation and to the writing and critical review of the manuscript.
Additional information: Supplementary Information accompanies this paper at www.nature.com/naturenanotechnology.
Competing financial interests: The authors have no conflict of interests.
Europe PMC Funders Group
Author Manuscript
Nat Nanotechnol. Author manuscript; available in PMC 2015 November 01.
Published in final edited form as:
Nat Nanotechnol. 2015 April ; 10(4): 361–369. doi:10.1038/nnano.2015.19.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Groningen, The Netherland 13Department of Neuroscience, Section Medical Physiology, 
University of Groningen, University Medical Center Groningen, Groningen, The Netherlands 
14Department of Internal Medicine IV and Institute of Medical Microbiology and Hygiene, 
University Medical Center, 79106 Freiburg, Germany 15Immunoregulation Laboratory, MRC 
Centre for Transplantation, King’s College London, Guys’ Hospital, London SE1 9RT, UK 16Royal 
College of Physicians, 11 St Andrews Place, Regent’s Park, London NW1 4LE, UK
Abstract
In humans and other mammals, it is known that calcium and phosphate ions are secreted from the 
distal small intestine into the lumen. However, why this secretion occurs is unclear. Here, we 
show that the process leads to the formation of amorphous magnesium-substituted calcium 
phosphate nanoparticles that trap soluble macromolecules, such as bacterial peptidoglycan and 
orally-fed protein antigens, in the lumen and transport them to immune cells of the intestinal 
tissue. The macromolecule-containing nanoparticles utilize epithelial M cells to enter Peyer’s 
patches - small areas of the intestine concentrated with particle-scavenging immune cells. In wild 
type mice, intestinal immune cells containing these naturally-formed nanoparticles expressed the 
immune tolerance-associated molecule ‘programmed death-ligand 1 (PD-L1)’, whereas in 
NOD1/2 double knock-out mice, which cannot recognize peptidoglycan, PD-L1 was undetected. 
Our results explain a role for constitutively formed calcium phosphate nanoparticles in the gut 
lumen and how this helps to shape intestinal immune homeostasis.
The active secretion of calcium by the gut is often referred to as the endogenous losses but 
why this should occur is not known as it contributes little to the homeostasis of calcium- its 
excretion being mediated through urine. Phosphate ions also flux between intestinal tissue 
and the lumen, so calcium phosphate precipitation may ensue1.These precipitates have not 
been thoroughly studied although a role in sequestration of bile acids and other colonic 
toxins has been proposed1. We have previously hypothesised that this process allows 
micrometre sized particles of calcium phosphate to form, which then adsorb other luminal 
components and carry them to phagocytic cells of intestinal tissue1-3. Herein we report the 
actual process: we show that, in fact, the endogenous luminal precipitates of mineralised 
calcium are abundant porous nanoparticles that appear to incorporate soluble molecules of 
the gut lumen and we present evidence for this process regulating the expression of cell 
surface PD-L1 on antigen presenting cells (APCs) in the sub-epithelial region of Peyer’s 
patches. PD-L1 is a cell surface immuno-inhibitory molecule that co-regulates T lymphocyte 
function and, especially, promotes immune tolerance.
Endogenous nanomineral of the intestinal lumen
Distal small intestinal contents, recovered from ileostomy patients, were air dried on plastic-
coated stubs for scanning electron microscopy (SEM). Extensive numbers of sub-
micrometre sized particles were identified (Fig. 1a-b). Their calcium and phosphorus rich 
elemental composition was confirmed by X-ray microanalysis (XRMA) and, repeatedly, 
magnesium was also present (Fig. 1c). High magnification SEM indicated that the particles 
were generally agglomerates of smaller, nanoparticulate structures (Fig. 1b).
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To avoid drying, and to better mimic in situ dispersion, whole cross-sections of non-aqueous 
resin embedded murine distal small bowel were then studied and transmission electron 
microscopy (TEM) was used to provide greater resolution. A large quantity of relatively 
electron dense nanoparticles was similarly visible (Fig. 1d) and these were again calcium 
(Ca) and phosphorus (P) rich by analysis with concomitant detectable magnesium (Mg) (Fig. 
1e and Supplementary Fig. 1). High power TEM imaging suggested that discrete particles 
were amorphous and porous in structure and ~100 nm (typically 75-150 nm) in diameter 
(Fig. 1f and Supplementary Fig. 1). Selected area electron diffraction confirmed the lack of 
crystallinity (Inset Fig. 1f). Although our observations imply that endogenous nanomineral 
particles occur in enormous numbers in the intestinal lumen, this enumeration exceeds 
current analytical capabilities. Median calcium concentration is 4.2 mM4, in 1L/24h of 
succus entericus (intestinal juice) of the human ileum, and a third of this calcium may 
precipitate5. Assuming a P:(Ca+Mg) molar ratio and packing density similar to octacalcium 
phosphate (because the former is variable and the latter is unknown for amorphous calcium 
phosphate), an average 100 nm diameter spherical particle and an estimated 50% void 
volume (porosity), we calculated that ~ 2 × 1014 luminal nanomineral particles/day will be 
present. This abundant endogenous nanomineral of amorphous magnesium-substituted 
calcium phosphate (AMCP) has not been previously observed or characterised, probably 
because standard processing techniques for microscopy and analysis would either dissolve 
the mineral or force agglomeration. Careful non-aqueous processing, however, reveals the 
disperse structures.
Gut immune cells acquire the endogenous luminal nanomineral
Non biological particles of ~20-250 nm diameter are known to efficiently cross the epithelial 
barrier of intestinal lymphoid follicles, notably the Peyer’s patches of the small intestine, 
and may accumulate in the underlying antigen presenting cells (APCs)3. We therefore 
studied frozen sections of both human and murine Peyer’s patches by light microscopy. 
Modified Von Kossa staining for mineralised phosphate revealed large numbers of positive 
cells within the sub-epithelial dome (Supplementary Fig. 2). Fluorescent calcein staining for 
mineralised calcium confirmed these observations (Fig. 2a-b) and demonstrated lysosomal 
localisation of the nanomineral (Supplementary Movie 1). A detector for back scattered 
electrons fitted to the SEM allowed the identification of regions with high elemental contrast 
in the same sub-epithelial dome area and the presence of calcium, phosphorus and 
magnesium were confirmed by X-ray microanalysis (Fig. 2c). Both human and murine 
tissue samples were similarly positive for these features.
Fluorescently labelled antibodies were then used to confirm an APC phenotype of these 
mineral-positive cells in murine and human Peyer’s patches. We noted that artefactual 
staining could occur for these cells, presumably through adsorption of the labelled antibody 
to the intracellular mineral. Hence, we were careful to ensure that, for phenotyping, all stains 
showed cellular distributions typical of the anticipated antigen location and not simply 
coincidental with the cellular areas rich in mineral. In addition to the nuclear stain we 
therefore only used double staining, namely calcein for the mineral plus one phenotypic 
marker at a time. The majority of human and murine calcein-positive cells were strongly 
positive for typical cell surface markers on dendritic cells residing in the Peyer’s patch sub-
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epithelial dome6,7, namely: CD11b, CD11c and HLA-DR (Fig 2d-r). A distinct sub-
population was also CD68high consistent with a mature macrophage phenotype (Fig. 2n and 
r). As expected in the gut the peripheral monocyte marker, CD14, was absent. Thus, overall, 
the mineral-positive cells of the Peyer’s patch sub-epithelial dome were phenotypically 
APCs.
Imaging with TEM and scanning transmission electron microscopy (STEM) revealed that 
the individual AMCP nanomineral structures in sub-epithelial dome APCs (Fig. 3a-b) were 
porous (Fig. 3a), and often clustered possibly due to adhesion to internal vesicle membranes 
as this is well known for nanominerals in cell lysosomes3. Moreover, the particles were of 
similar shape, electron density and amorphous appearance to their luminal counterparts but 
generally appeared smaller (e.g. Fig. 3a versus Fig. 1f) indicating, perhaps, partial 
intracellular degradation. Apparent similarities in composition by imaging were confirmed 
analytically for Ca, Mg and P content, using standardless elemental quantification of X-ray 
microanalysis spectra from similar thin sections of Peyer’s patches and luminal contents 
(Fig. 3c).
This tendency for intracellular clustering of AMCP nanomineral particles facilitated 
tomographic 3-D imaging. A large intracellular cluster was identified and imaged using high 
angle annular dark field (HAADF) STEM to enable sufficient contrast with unstained non-
aqueous-resin-embedded specimens (Fig. 3d). A tilt series was recorded and reconstructed in 
three dimensions which demonstrated particles of markedly varying sizes (Fig. 3e and 
Supplementary Movie 2), consistent with intracellular AMCP nanomineral at differing 
stages of dissolution. Taken together the data above suggested that luminally formed 
nanomineral tracks to Peyer’s patch APCs and we sought to confirm this with three specific 
investigations.
The first study involved dietary manipulation of the main nanomineral elements. Systemic 
calcium and phosphate levels are tightly controlled in mammals through the large skeletal 
pool. In contrast, the secretion of calcium from the circulation and into the intestinal tract 
(i.e. endogenous losses) diminishes when animals are maintained on low calcium diets (e.g. 
0.1 g Ca/kg diet for 3 weeks versus 5 g Ca/kg diet normally)8. Thus, quantitative changes to 
the Peyer’s patch APC nanomineral, in response to dietary calcium and phosphorus 
deprivation, would strongly indicate a lumen-to-APC pathway since systemic and 
intracellular levels of these vital elements are so carefully conserved9. We took snap frozen 
Peyer’s patch tissue from four groups of mice fed diets with varying levels of these elements 
for three weeks. Peyer’s patches of all four groups revealed abundant sub-epithelial dome 
cells that stained normally for mineralised calcium (Supplementary Fig. 3a-b). However, X-
ray microanalysis with SEM indicated that this mineralised calcium was markedly 
phosphate deficient for the two groups of mice ingesting the low dietary calcium and 
phosphorus diets (< 0.3 g/kg diet for either element: Supplementary Fig. 3c). Moreover, 
mineral analysis was as expected for mice ingesting diets replete in calcium and phosphorus 
(> 3.8 g/kg diet for either element: Supplementary Fig. 3d). Using quantitative nuclear 
microscopy2 mean P:Ca ratios of 1.15 (w/w) (Fig. 3f) were identified for nanomineral of the 
Peyer’s patch sub-epithelial dome from mice on calcium and phosphorus replete diets. 
However, phosphate was absent from the mineral of mice on the diets that were low in 
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calcium and phosphorus (Fig. 3f). The findings support a lumen-to-Peyer’s patch route for 
the endogenous AMCP nanomineral.
The second study considered the presence of the nanomineral in Peyer’s patches of mice that 
lacked M cells. Transport into the Peyer’s patch, of other non-biological particles in the size 
range of the endogenous nanomineral, is a well described phenomenon and is chiefly 
mediated by specialist epithelial M cells3,10. We therefore compared the relative abundance 
of Peyer’s patch nanomineral by confocal microscopy in villin-cre+ RANKFL/FL mice where 
RANKL-dependent intestinal M cell differentiation is prevented by conditional deletion of 
RANK in the intestinal epithelium11. In these mice M cells were absent from the follicle-
associated epithelium overlying the Peyer’s patches (Fig. 4a) and calcein-stained 
nanomineral was faint and a rare occurrence (Fig. 4b-c). In contrast, in matched control mice 
with functional RANKL-RANK signalling (i.e. RANKFL/FL mice) M cells were abundant 
(Fig. 4a) and calcein staining was normal (Fig. 4b-c).
Finally, we determined the AMCP nanomineral status of murine lymphoid structures from 
the large intestine. Forming a blind end tract off the caecum is the appendix, where luminal 
contents may reside for long periods and there is also a very large area of caecal patch. 
However, hyper-exposure of caecal patch immune cells to luminal contents is probably 
averted through regulation of M cell maturation12: as such the Peyer’s patch and the caecal 
patch are very similar in terms of developmental processes as well as immunological 
structure and function13. Indeed, we confirmed that, just as for the Peyer’s patch, calcein-
detectable mineral was also observed in caecal patch sub-epithelial immune cells 
(Supplementary Fig. 4). In contrast, the colon appears to have little capacity for particle 
uptake14. Consistent with this, we found no evidence for calcein-detectable mineral in 
lymphoid follicles of the colon although often it was detected above the apical surface of the 
epithelium of regular mucosa and lymphoid structures (Supplementary Fig. 4), perhaps due 
to retention in the thick adherent mucus layer of the colon14.
Collectively these data indicate that the endogenous intestinal AMCP nanomineral forms in 
the lumen and enters APCs of intestinal immune-inductive sites, namely the caecal and 
Peyer’s patches, predominantly via epithelial M cells.
The endogenous nanomineral transports luminal macromolecules
The abundant homogenous formation of porous calcium phosphate nanomineral in the 
intestinal lumen, and its marked transport across M cells into lymphoid patch APCs, led us 
to question function. Calcium phosphates excel at trapping and carrying organic material 
into cells15. Indeed the nanomineral described here is amorphous, which contrasts with other 
forms of calcium phosphate in biological systems such as octacalcium pentophosphate and 
biological apatite16, and this could facilitate its intracellular dissolution enabling the release 
of trapped organic material. In other words, a constitutive ‘cargo ship’ function for the 
endogenous intestinal nanomineral was considered whereby soluble, luminal organic 
macromolecules could be encapsulated and then transported to gut APCs.
A number of studies have confirmed the existence of discrete pathways for handling 
exogenously-derived cargo of differing origin at the subcellular level following the seminal 
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work of Blander and Medzhitov17,18. Particulate and soluble molecules are not anticipated 
to show co-incidental intracellular fluorescent signals unless their uptake is as a single 
conjugate19-21. Therefore, in the absence of in vivo imaging techniques that could track 
cargo-loading of single nanoparticles, and then show their transport from the intestinal 
lumen to Peyer’s patch cells, we considered the intracellular co-incidence of the AMCP 
nanomineral with luminally-derived molecules in sub-epithelial APCs.
We fed BALB/c mice, maintained on a conventional diet or a calcium and phosphorus 
deplete diet, with Texas Red®-labelled ovalbumin or unlabelled ovalbumin, respectively. 
After 4 hours, the protein detected in Peyer’s patches of mice on a conventional laboratory 
diet was almost solely compartmentalised within the AMCP nanomineral-positive APCs of 
the sub-epithelial dome (Fig. 5a-e). Since it remained possible that ovalbumin and the 
fluorochrome were cleaved during digestion, only the latter being associated with the 
nanomineral, we also directly stained the Peyer’s patch sections for ovalbumin. Clear 
colocalisation was still observed, using the Huygens maximum least expected deconvolution 
algorithm to optimise resolution (Fig. 5f). Additionally, close but separated signals for 
intracellular calcein (AMCP nanomineral) and protein were observed (Fig. 5f): this should 
be expected if the nanomineral dissolves intra-lysosomally unmasking, and then releasing, 
its cargo. Similar findings were observed for mice fed ovalbumin on the calcium and 
phosphate deplete diet (Fig. 5g-k) even though, under these conditions, the nanomineral was 
calcium-rich but no longer a calcium phosphate (Supplementary Fig. 3c and Fig. 3f). Thus, 
endogenously formed nanoparticles of mineralised calcium appear to trap protein antigen in 
the gut lumen and chaperone it to Peyer’s patch APCs.
Microbial associated molecular patterns (MAMPs), such as peptidoglycan, are present 
ubiquitously in the lumen of the distal gastrointestinal tract, including the ileum, due to 
turnover of the commensal microbiota. Peptidoglycan has been identified in human and 
rodent gut mucosa by the monoclonal antibody 2E922, which recognises only degraded/free 
peptidoglycan and not that present in whole bacteria23. Here, using 2E9 antibody, we 
showed that, just as for dietary-derived ovalbumin, bacterial-derived peptidoglycan was also 
compartmentalised with the AMCP nanomineral of Peyer’s patch APCs again in terms of 
inseparable fluorescent signals and also as separate but closely adjacent signals (Pearson 
correlation coefficient = 0.71) (Figure. 5l-o).
Collectively the findings above pointed to role for endogenous gut nanomineral, which is 
functionally conserved in spite of dietary calcium and phosphate deficiency, in the selection 
and chaperoning of luminal macromolecules to Peyer’s patch APCs. Notably, these organic 
macromolecules, as well as the Mg ions of AMCP, may serve to stabilise the particle in its 
amorphous state for the lifetime of the nanomineral24,25.
Finally, we considered how the process described above may contribute to normal intestinal 
homeostasis.
Peptidoglycan potently stimulates the upregulation of the immunotolerance-associated co-
regulatory molecule PD-L1 (B7-H1/CD274) on the cell surface26. Whether this mechanism 
extends to the gut is unclear because APCs are conditioned locally and, at least in terms of 
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pro-inflammatory signalling, are refractory to stimulation by bacterial fragments27. We 
therefore investigated the PD-L1 status of AMCP+ cells of murine Peyer’s patches in both 
wild type mice and in NOD1 and NOD2 double knock out mice (NOD1/2−/−)28 which 
cannot recognise peptidoglycan. In wild type mice these cells were consistently PD-L1high 
(Fig. 6a and c). In contrast, in NOD1/2−/− mice, PD-L1 was undetectable on AMCP+ cells 
(Fig. 6b and d). In both wild type and NOD1/2−/− mice, sporadic low-moderate background 
PD-L1 expression was observed in the patch (Fig. 6a and b). This selective failure of PD-L1 
expression in APCs of the intestinal nanomineral-antigen-peptidoglycan pathway indicates 
that peptidoglycan signalling must be intact to enable PD-L1 upregulation.
The intestinal immune response to orally-delivered protein involves cooperation between 
Peyer’s patches and mesenteric lymph nodes. In particular, migration of APCs to the 
mesenteric lymph nodes implies functional activity (i.e. antigen presentation) and we 
confirmed that mesenteric lymph nodes in wild type mice had significant numbers of AMCP 
nanomineral+ cells (Fig. 6e and g). These were PD-L1+, as in Peyer’s patches, while in the 
NOD1/2−/− mice PD-L1 was again absent (Fig. 6f and h).
Collectively, these data suggest that in the absence of peptidoglycan recognition, antigen of 
the nanomineral pathway may be presented by APCs to T cells without the co-regulatory 
molecule PD-L1 and perhaps, therefore, without a tolerogenic instruction29. In this respect, 
it is interesting to note that in Crohn’s disease peptidoglycan recognition is known to be 
compromised in many patients, mostly due to mutations in NOD230, and that the earliest 
signs of disease appear to overlie lymphoid follicles such as Peyer’s patches31. Hence, 
whether this patient group represents the result of compromised PD-L1 expression in the 
nanomineral-antigen-peptidoglycan pathway should now be investigated.
Conclusions
Peyer’s patch sampling of luminal contents, which will include some undigested dietary 
antigen, has long been recognised and is widely considered to be a form of local 
immunosensing and surveillance6. We now provide evidence that at least part of this process 
is mediated by an endogenous nanomineral chaperone, from lumen to APC, and that co-
delivery of peptidoglycan in this pathway conditions the APC phenotype by switching on 
PD-L1. It is possible that MAMPs other than peptidoglycan are trapped and delivered to 
APCs in this fashion. However, at least for imprinting PD-L1 expression, they do not appear 
to signal as deficiency in NOD1 and NOD2, and hence peptidoglycan recognition, was 
sufficient to prevent PD-L1 expression in this pathway (Fig. 6). PD-L1 is immuno-inhibitory 
and is normally up-regulated during inflammation to help minimise tissue damage29. Failure 
to express PD-L1 in the intestine enhances the risk of inflammation32,33 but especially so 
when non-self antigen is being expressed34. Thus, not only might the nanomineral pathway 
ensure that luminal antigen and peptidoglycan reach sub-epithelial immune cells without 
enzymatic degradation en route but, additionally, it could ensure that the very cells in receipt 
of exogenous non-self antigens are also the ones expressing PD-L1. An acquired PD-L1high 
phenotype, in a minority of APCs that are selected to be in sync with the surveillance of 
soluble luminal contents, could ensure that tolerogenic signalling towards ‘harmless antigen’ 
is not overly dominant and, for example, that immune responsiveness towards invasive 
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pathogens is maintained. Interestingly, the process adapts and remains fully functional under 
conditions of extreme dietary calcium and phosphate deficiency implying a degree of 
criticality in its function.
Overall, we propose that our findings explain: (a) why the Peyer’s patch has such a 
remarkable ability for the uptake of non-biological nanoparticles in the ~20-250 nm 
range35,36; (b) how under constitutive conditions, luminal antigen and peptidoglycan can 
reach APCs of the Peyer’s patch sub-epithelial dome without prior enzymatic degradation; 
(c) how the commensal microbiota can influence local APC development and potentially 
calibrate susceptibility to inflammatory disease and (d) why endogenous calcium losses 
occur into the gut lumen37. Our data also provide evidence for constitutive and beneficial 
self-assembly (i.e. without an associated scaffold) of nanoparticles in humans yielding new 
insights into the interplay between nutrition, gut physiology and the mucosal immune 
system. Finally, Peyer’s patches are present at birth6 and mineralised calcium nano-
structures probably exist in breast milk38-40. We speculate from the findings presented here 
that the nanomineral in breast milk may be more than an easily-absorbed form of calcium 
and facilitate early gut immuno-surveillance of maternal milk-borne antigens41.
METHODS
Tissue sampling
Human samples were from St Thomas’ Hospital (London) with appropriate ethical approval. 
Fresh surgical human ileal tissue specimens (n=6 patients) were each about 20 mm by 20 
mm in size. Samples were macroscopically normal and were the resection margins of tissue 
from patients undergoing surgery for Crohn’s disease (n=2), large bowel carcinoma (n=2) 
and non Crohn’s colitis (n=2). Luminal contents were provided from anonymised patients 
with ileostomies. Wild type (C57BL/6) murine ileal and large bowel tissues, as well as 
mesenteric lymph nodes, were obtained as surplus to requirement (LMB, Addenbrookes 
Hospital, Cambridge), or were from specific feeding studies8 (as decribed in the text) or 
were matched controls for murine models (all on C57BL/6 background) described below. 
All tissues or tissue contents were either (i) snap frozen in liquid nitrogen-cooled isopentane 
and then stored, unprocessed or in OCT freezing medium (Thermo Scientific, USA), in 
liquid nitrogen until further use or (ii) were processed and embedded in non-aqueous resin 
(Quetol651™-see below), as stated in the text.
M cell deficient villin-cre+ RANKFL/FL mice
Villin-cre+, but not villin-cre−, RANKFL/FL mice fail to express intestinal M cells as their 
differentiation is inhibited due to blockade of RANKL-RANK signalling11. Tissues from 
these mice, sustained on a normal laboratory chow diet, were studied. For whole-mount 
staining, Peyer’s patches were dissected and fixed with BD Cytofix/Cytoperm (BD 
Biosciences, Oxford, UK). For analysis of M cells in tissue sections, Peyer’s patches were 
removed and snap-frozen at the temperature of liquid nitrogen. Serial frozen sections (5 μm 
in thickness) or tissues were subsequently immunostained with rat anti-mouse GP2 mAb 
(MBL International, Woburn, MA). Following addition of primary Ab, tissues were stained 
with Alexa Fluor 488-conjugated anti-rat IgG Ab (Invitrogen, Paisley, UK) and 
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counterstained with either Alexa Fluor 647-conjugated phalloidin (Invitrogen) or DAPI. 
Sections were mounted in fluorescent mounting medium (Dako, Ely, UK) and examined 
using a Zeiss LSM710 confocal microscope (Zeiss, Welwyn Garden City, UK). Calcein 
staining and imaging was undertaken as below (staining and immunofluorescence) for 
regular wild type mice. For quantitation sections from the villin-cre− (M cell normal) and 
villin-cre+ (M cell deficient) RANKFL/FL mice were sectioned, stained and imaged as 
blinded pairs to ensure precisely the same sample preparation and imaging parameters. 
Quantification of AMCP was carried out, on blinded sections, by manual selection 
(designation) of the sub epithelial dome area and then ImageJ open source software42 was 
used to acquire the percentage area of calcein staining. Differences in the percentage area of 
calcein staining between the villin-cre− and villin-cre+ mice were assessed by Mann-
Whitney test.
NOD1 and NOD2 double deficient mice
NOD1/2 double knock out mice (NOD1/2−/−) were first generated and characterised in the 
group of Stephen Girardin (Toronto, Canada) and shipped to the Department of Pathology, 
Academic Medical Center, University of Amsterdam, for further study28. Peyer’s patches 
and mesenteric lymph nodes were freshly dissected from animals that were surplus to 
requirement and that had been sustained on a standard laboratory chow diet. Tissues were 
snap frozen and shipped to Cambridge (MRC HNR) for sample preparation and imaging. 
Calcein staining and imaging was undertaken as below (staining and immunofluorescence) 
for regular wild type mice: sections from NOD1/2−/− and wild type mice were sectioned, 
stained and imaged in pairs to ensure precisely the same sample preparation and imaging 
parameters.
OVA feeding study and dietary mineral deprivation
Adult female BALB/c mice, 6-8 weeks of age, were purchased from Harlan Olac (Bicester, 
U.K.) and kept under specific pathogen-free conditions. To determine co-localization of 
ovalbumin and endogenous nanominerals, mice received either 1 mg of Texas Red®-
labelled or unlabelled ovalbumin (Invitrogen, Paisley, UK), as stated in the text, dissolved in 
0.2 ml phosphate buffered saline by oral gavage using a stainless steel gavage needle. Four 
hours later small intestines were harvested for analysis. All experimental procedures were 
performed in accordance with the Home Office Animals Scientific Procedures Act (1986). 
Detailed information of diets is in Pele et al, 2007 (ref 8). Briefly, diets were formulated by 
Harlan-Teklad and consisted of a baseline diet (the very low Ca diet) that had a natural 
molar calcium:phosphate ratio of 0.3:1. Increased Ca levels in the subsequent diets were 
through addition of dibasic calcium phosphate (CaHPO4.2H2O) and calcium carbonate 
(CaCO3) to achieve a calcium:phosphate ratio of 1.3:1 (i.e. normal ratios of these elements 
in a standard rodent non-purified diet). Final Ca levels of the diets were 0.009% for the very 
low, 0.05% for the low, 0.5% for the normal, and 1.5% for the high Ca diets.
Scanning electron microscopy (SEM) and elemental analysis of tissue samples
Tissue samples were cryo-sectioned on a Leica CM30505 cryostat, set at −24 °C, with a 
section thickness of ~10 μm. Resulting sections were air dried on to Melinex films and 
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subsequently attached to SEM stubs with silver dags (Agar, UK). They were carbon-coated 
before being placed in the SEM chamber for analysis. The samples were imaged with a 
Philips/FEI XL30 field emission gun (FEG) SEM using secondary or back scattered electron 
detectors as noted in the text. Energy Dispersive X-ray Spectroscopy (X-ray microanalysis) 
was carried out at 20 kV using an Oxford Instruments ATW SiLi spectrometer running their 
INCA software.
Transmission electron microscopy and elemental analysis
Human and murine samples were fixed in 2% acrolein in polypropylene glycol, dehydrated 
in ethanol and embedded in ‘Quetol 651’ epoxy resin. The resin was cured at 60 °C and 
sections were cut to 70 nm thicknesses before mounting on TEM grids. To allow the 
endogenous nanomineral to be easily visualised in a tissue background we avoided the use 
of heavy-metal contrast agents (e.g. uranyl acetate and lead citrate) leaving sections 
unstained. Sections were examined in a FEI CM200 FEG-TEM operating at 200 kV and 
fitted with an Oxford Instruments ultra-thin window energy dispersive X-ray (EDX) 
spectrometer and a Gatan imaging filter (GIF 200). We imaged at magnifications that would 
readily allow particles > 20 nm in diameter to be observed. The elemental content of 
visualised particles was measured in the TEM by focussed probe-EDX spectroscopy. Ca/P 
or [Ca(+Mg)]/P ratios were determined from the Oxford Instruments ISIS processing 
software using virtual standards for the Mg, Ca and P Kα X-ray peaks, monitored at a take-
off angle of 20° and a specimen tilt angle of 15°. Care was taken to minimise the intensity of 
the incident electron beam because calcium phosphate particles are susceptible to irradiation 
damage by the high energy electrons; this results in significant mass loss for materials such 
as hydroxyapatite which can decompose to calcium oxide following prolonged 
exposure43,44. Selected area electron diffraction (SAED) was conducted using a selected 
area aperture of approximately 0.18 μm diameter in the image plane.
Scanning transmission electron microscopy and 3 dimensional tomography
Murine samples were fixed and embedded as above. Tomography experiments based on 
high-angle annular dark-field (HAADF) imaging in the scanning transmission electron 
microscopy (STEM) mode were performed at 200 kV on a FEI Tecnai F20 FEG-TEM 
tilting the sample from −42° to +70° at 2° intervals about a single axis using a Fischione 
2020 ultra-high-tilt tomography holder. Using the Inspect 3D software, tilt series were 
aligned by cross-correlation and reconstructed using the SIRT algorithm (with 20 iterations).
Nuclear microscopy
Particle-induced X ray emission was carried out as previously described2 using the 
microbeam facility of the Surrey Ion Beam Centre, Guildford UK 
[www.ionbeamcentre.co.uk]. The samples were mounted in the sample chamber of the 
nuclear microprobe at the University of Surrey Ion Beam Centre and were scanned using a 
beam of 3 MeV protons from a 2 MV Tandetron accelerator focused to a diameter of 1–2 
μm. The average beam current varied between 100 pA and 200 pA. Induced X-rays were 
detected using a lithium-drifted silicon detector at a variable distance of 20–50 mm from the 
sample (Gresham Scientific Ltd., 80 mm2 active area). Based upon parallel confocal 
microscopy observations, elemental maps ranging from 1 × 1 mm2 to 100 ×100 μm2, were 
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recorded. PIXE spectra from individual particles were recorded by positioning the beam on 
each particle area sequentially. Unpaired, 2-tailed student t tests were applied to assess 
differences between low Ca/P and high Ca/P diets.
Confocal microscopy
Work with traditional paraffin-embedded specimens indicated that endogenous 
nanominerals were lost and/or artefactually mobilised during processing and so all confocal 
microscopy was carried out on frozen sections. Peyer’s patches were cryo-sectioned (Leica 
CM3050S) at 12 μm and collected on SuperFrost® slides (Thermo Scientific, USA) and 
allowed to air dry for 30 min at room temperature. Unless otherwise stated, sections were 
imaged with a Leica SP2 confocal microscope (Leica Microsystems, Germany) at 488, 568 
or 633 nm laser lines, fitted with diode Ar/ArKr and HeNe lasers, using either a ×25 multi-
immersion lens or a ×63, 1.2 NA water objective lens. Data were recorded using the Leica 
Confocal Software (v2.61) and images processed using the open-source ImageJ software42. 
Data were collected as 8-bit greyscale images and assigned appropriate colours 
subsequently: nuclei are shown grey or blue to best facilitate visualisation of the non-nuclear 
stains (i.e. calcein and fluorescent antibodies against ovalbumin, peptidoglycan and cell 
surface markers).
Staining and Immunofluorescence
Staining for endogenous nanomineral
Modified Von Kossa Staining: Sections were fixed in 10% w/v formaldehyde-PBS 
(Sigma) for 10 min followed by immediate washing in ultra high purity (UHP) water for 5 
min. The washed sections were placed in a Coplin jar containing 1% silver nitrate solution 
and incubated for 1 h at room temperature, then washed in UHP water for 5 min. The 
sections were covered with UHP water and incubated under ultraviolet light for 1h, followed 
by a dip in 5% sodium thiosulphate solution for 5 min to remove the un-reacted silver. After 
a final wash in UHP water for 5 min, sections were counter stained with haematoxylin 
solution for 1 min, washed and dehydrated using three changes of IMS and cleared with 
three changes of xylene. The sections were coversliped using xylene based DPX.
Calcein staining: Sections were fixed in 2% formaldehyde-PBS (Sigma) for 10 min and 
then washed in three changes of 0.1 M Tris-HCL buffer, for 3 min each. Fixed sections were 
incubated with 2.5 μM calcein Tris-HCL solution in a glass coplin jar for 20 min at room 
temperature and with light exposure restricted to the minimum. Following incubation, the 
sections were washed carefully with three changes of 0.1 M Tris-HCl buffer for 3 min each.
Double staining for endogenous nanomineral and phenotypic markers—
Murine sections were fixed using 4% (w/v) formaldehyde-PBS (Sigma) for 10 min and then 
washed with 3 changes of Tris-buffered saline (TBS) at pH 8.2. Sections were then blocked 
for 2 h using 5% goat serum (PAA Laboratories, UK), 1% bovine serum albumin (Sigma), 
0.3 M glycine (Sigma) and 0.1% Triton X-100 (Sigma) in TBS and washed with 3 changes 
of TBS. Primary antibodies for CD11c and CD11b were next applied and incubated for 1 h 
and 4 h respectively. Following washing with 3 changes of TBS, sections were then 
incubated with secondary antibodies, for 1 h, and finally washed with 3 changes of TBS. 
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Primary antibodies were Rat anti-mouse CD11b (M1/70) (Biolegend, USA) at 1:200 
working concentration and Hamster anti-mouse CD11c (N418) (AbD Serotec, UK) at 1:100 
working concentration. Secondary antibodies were Goat anti-rat IgG (H+L) Alexa Fluor® 
568 (Invitrogen, UK) at 1:200 working concentration and Goat anti-hamster IgG (H+L) 
Alexa Fluor® 568 (Invitrogen, UK) at working concentration 1:200.
Human sections were fixed in 2% formaldehyde (4 °C, 10 min), washed with 0.1 M Tris 
buffer (pH 8.0) and incubated with primary antibodies for CD68, HLA-DR and CD14 for 1 
h at room temperature (RT), and for CD11b and CD11c overnight at 4°C. After further 
washing in 0.1 M Tris buffer, the slides were then incubated with biotinylated secondary 
antibodies (diluted in foetal calf serum 1:250, v/v) for 1 h at RT and labelled with Alexa 
Fluor® 568 conjugated streptavidin to enable detection (1 h, RT). All sections (i.e. murine 
and human) were finally stained with calcein for endogenous nanomineral and 
counterstained with To-Pro 3 (Invitrogen, UK) or propidium iodide respectively. Sections 
were washed with three changes of TBS and permanently mounted with ProLong® gold 
antifade reagent (Invitrogen, UK). These cell surface antigens were all confirmed in specific, 
positive-control tissues that contain cells expressing these markers (namely appendix, 
placenta and tonsil).
Double staining for endogenous nanomineral and PD-L1—Murine sections were 
fixed using 4% (w/v) formaldehyde-PBS (Sigma) for 10 min and then washed with 3 
changes of Tris-buffered saline (TBS) at pH 8.2. Sections were then blocked for 1 h using 
10% goat serum (PAA Laboratories, UK), 1% bovine serum albumin (Sigma), 0.3 M 
glycine (Sigma) and 0.1% Triton X-100 (Sigma) in TBS and washed with 3 changes of TBS. 
The primary antibody for PD-L1 (10F.9G2) (Biolegend, USA) was next applied and 
incubated for 1 h. Following washing with 3 changes of TBS, sections were then incubated 
with Goat anti-rat IgG (H+L) Alexa Fluor® 568 (Invitrogen, UK) at 1:200 working 
concentration, for 1 h, and finally washed with 3 changes of TBS.
Staining for endogenous nanomineral and dietary antigen, bacterial 
peptidoglycan and lysozyme—Dual staining for the dietary protein ovalbumin and for 
endogenous nanomineral was achieved using OVA-Alex Fluor® 633 and calcein, 
respectively, and as described above for murine sections. Staining for bacterial 
peptidoglycan was achieved by using the mouse Mab 2E9 (mouse IgG3)23. Briefly, human 
sections were fixed in 2% formaldehyde (4 °C, 10 min). After three washes in Tris buffer 
(pH 7.4), sections were blocked in 1% BSA/Tris buffer and then incubated with biotinylated 
2E9 (diluted 1:500 in Tris buffer) overnight, at 4°C. After further washing, sections were 
subsequently incubated with streptavidin (1:100, 30 min, RT) and with TSA (1:100, 10 min, 
RT). Endogenous nanomineral staining and nuclear counterstain were finally carried out as 
described above for sections of human tissue.
Lysosomal staining was by anti-lysozyme antibody. Sections of human Peyer’s patch were 
fixed in 4% PFA (10 minutes), blocked with normal serum (5% goat serum, 1% BSA in 
PBS at pH 7.8 for 1 hour at room temperature) and incubated with mouse anti-lysozyme 
(Clone: [BGN/06/961]; Abcam, UK) at 1:50 dilution and 4 °C overnight. The primary 
antibody was detected using goat anti-mouse Alexa Fluor® 568 antibody (1:200 1 hour, 
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room temperature; Invitrogen, UK). AMCP nanomineral was stained with calcein (0.001M, 
30 minutes, room temperature; Sigma, UK) and the nuclei stained with Hoescht 33342 (2 
μg/ml, 20 minutes, room temperature).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Characterisation of endogenous mineral of the intestinal lumen
Distal small bowel contents from humans (a-c) and mice (d-f) visualised by electron 
microscopy (EM) and analysed for elemental composition (c and e) and crystallographic 
phase (f inset). a, b – SEM at low (a; scale bar, 1 μm) and high (b; scale bar, 500 nm) 
magnification with standardless X-ray microanalysis (c) of 11 separate particle regions 
(mean + SD). d, f – TEM at low (d; scale bar, 2 μm) and high (f; scale bar, 100 nm) 
magnification. Inset f – Selected area electron diffraction demonstrated the absence of any 
significant crystallinity. e – A typical energy dispersive X-ray microanalysis spectrum 
showing the elemental composition of an endogenous mineral particle (note the Cu signal is 
generated by the TEM specimen support grid and the C by the embedding resin).
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Figure 2. Phenotypic and nanomineral characterisation of sub-epithelial dome (SED) cells in 
murine and human Peyer’s patches (PP)
a – Human PP SED stained for nuclei by propidium iodide (grey) and for mineralised 
calcium by calcein (green) and visualised by confocal microscopy. The gap between the 
epithelial cells (delineated apically by the broken white line) and cells of the SED is a 
consequence of frozen sectioning. Scale bar, 50 μm. b – The punctate nature of the stained 
mineral, shown from higher resolution 3D reconstructed confocal images, is consistent with 
localisation to distinct intracellular vesicles. Scale bar, 20 μm. c –Typical energy dispersive 
X-ray microanalysis of the mineral. d-m- Confocal micrographs of mouse SED stained with 
To-Pro-3 for nuclei (grey, images d and i), plus either anti-CD11b (red; image e) or anti-
CD11c (red, images j), and calcein for endogenous mineral (green, images f and k). Overlay 
images in g and l confirms an APC phenotype (i.e. CD11b+ and Cd11c+) of the calcein+ 
cells. Scale bars, 50 μm. n-r – Phenotype of the calcein+ cells (green) of the SED in humans: 
n-q shows representative staining for CD68 (red), CD11b (red), CD11c (red) and HLA-DR 
(red), respectively. Scale bars; 50 μm. r – % calcein+ cells that express these markers (n = 6) 
again confirming an APC phenotype for these cells.
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Figure 3. EM characterisation of murine endogenous nanomineral and 3D nanotomography
a – Examples by bright field TEM and b – HAADF STEM imaging of clusters of 
endogenous nanomineral within cells of the Peyer’s patch (PP) sub-epithelial dome (SED). 
Scale bar, 100 nm. c –Calcium, magnesium and phosphorus composition of endogenous 
nanomineral in PP SED (n = 20 separate regions, black) or the murine intestinal lumen (n = 
22 separate regions, white), by standardless X-ray microanalysis, Mean + SD. d – A large 
cluster was imaged by HAADF STEM and e – a tilt series was reconstructed for 3D 
visualisation; XY orthoslice from the 3D reconstruction where particles and internal porosity 
are observed. Scale bars, 100 nm and 200 nm, respectively. f – Quantitative P:Ca ratios of 
the nanomineral of the SED by nuclear microscopy for mice on low (grey squares) and very 
low (black squares) Ca and P diets versus those on normal (open squares) or high (red 
squares) Ca and P diets. Horizontal bars represent the mean for each group. **** p< 0.0001 
versus grey/black, Mann-Whitney test.
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Figure 4. AMCP nanomineral uptake from the gut lumen into Peyer’s patches is substantially 
impeded in the absence of M cells in the follicle associated epithelium
a – Upper panels. Whole-mount immunohistochemistry showing that GP2-expressing M 
cells (green, arrows in lower panels) are absent in the follicle associated epithelium (FAE) of 
villin-cre+ RANKLFL/FL mice (right-hand panels) when compared to villin-cre− 
RANKLFL/FL control mice (left-hand panels). Tissues are counterstained to detect F-actin 
(blue). Scale bars, 200 μm. Lower panels show immunohistochemistry analysis of frozen 
sections of Peyer’s patches from the same mice. Sections are counterstained with DAPI to 
detect cell nuclei (blue). Scale bars, 100 μm. Dashed lines indicate the boundary of the FAE. 
SED, sub-epithelial dome; V, villi. b – Calcein staining (green) for mineralised calcium 
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(white arrows) in villin-cre+ RANKLFL/FL mice (right-hand panel) compared to staining in 
villin-cre-RANKLFL/FL control mice (left hand panel); sections are counterstained with 
ToPro3 to detect cell nuclei (grey) and c – quantification of staining in the two groups, ** p 
= 0.0025, Mann-Whitney test.
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Figure 5. Endogenous nanomineral is co-localised with luminal peptidoglycan and dietary 
antigen in Peyer’s patch (PP) APC
a-k –Mice were fed a normal (a-f) or low (g-k) Ca/P diet plus fluorescently-labelled 
ovalbumin. (a-e and g-k) PP sections were stained with To-Pro-3 for nuclei (grey, images a 
and g), and with calcein for the endogenous nanomineral (green, images c and i). The 
fluorescent-labelled ovalbumin (red) is shown in b and h and the overlay of all three stains 
shows inseparable signals for ovalbumin and the nanomineral in d, e and j, k. Scale bar, 50 
μm (a-e) and 100 μm (g-k). f – 3D stack, with Huygens Maximum Likelihood Estimation 
deconvolution, visualised with calcein staining for the endogenous nanomineral (green) and 
with antibody staining for ovalbumin (red). To-Pro-3 is the nuclear counterstain (grey). Both 
inseparable co-localisation (orange/yellow) as well as close separation of the protein and 
mineralised calcium signals are observed, consistent with the partial release of ovalbumin 
from the nanomineral as it dissolves in the cell lysosome. Scale bar, 20 μm. l-o – Human PP 
sections were stained with To-Pro-3 for nuclei (grey, l), with 2E9 antibody for 
peptidoglycan (red, m) and calcein for endogenous nanomineral (green, n). The overlay 
image in o shows the co-localisation of endogenous nanomineral and peptidoglycan 
implying that the nanomineral transports bacterial peptidoglycan as well as the protein 
antigen shown above. Scale bars, 25 μm.
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Figure 6. Peptidoglycan signalling is required for PD-L1 expression on nanomineral-positive 
APCs of the Peyer’s patch sub-epithelial dome and mesenteric lymph nodes
Confocal micrographs showing PD-L1 expression (red) of wild type mice and NOD1/2−/− 
mice in (a, b) the Peyer’s patch, (c, d) representative nanomineral+ cells (green) of the 
Peyer’s patch, (e, f) mesenteric lymph nodes (nanomineral in green) and (g, h) 
representative nanomineral+ cells of the mesenteric lymph nodes. Nuclei are shown in blue 
in low power images (a, b, e and f) and in grey in high power images (c, d g and h). Direct 
overlap of the green and red appears orange/yellow. Scale bars are 100 μm (a, b), 5 μm (c, d, 
g and h) and 50 μm (e, f).
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